Alexander Navarini
Overview
Explore the profile of Alexander Navarini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
844
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lichtenberger R, Maul L, Birkenmaier I, Oyanguren I, Ak M, Heidemeyer K, et al.
Acta Derm Venereol
. 2025 Feb;
105:adv42296.
PMID: 39916484
Real-world data on gender differences in quality of life among psoriasis patients before and during treatment are scarce. This study analysed data of 748 adults with moderate-to-severe psoriasis enrolled in...
2.
Martinovic A, Mantovani M, Trpchevska N, Novak E, Milev N, Bode L, et al.
Front Aging
. 2024 Dec;
5:1495029.
PMID: 39659760
Longevity medicine is an emerging and iterative healthcare discipline focusing on early detection, preventive measures, and personalized approaches that aim to extend healthy lifespan and promote healthy aging. This comprehensive...
3.
Vasconcelos-Berg R, Desyatnikova S, Bonavia P, Chammas M, Navarini A, Sigrist R
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594210
The midface is a key area in facial aesthetics, highly susceptible to age-related changes such as fat pad absorption, bone resorption, and loss of skin elasticity. These changes lead to...
4.
Birkenmaier I, Maul L, Oyanguren I, Sorbe C, Frohlich F, Schlapbach C, et al.
Arch Dermatol Res
. 2024 Oct;
316(9):654.
PMID: 39352439
Real-world data on anatomically localized psoriasis and its response to systemic therapy across different age-groups and sexes is limited. This study aimed to evaluate the severity and distribution of psoriasis...
5.
Roider E, Lakatos A, McConnell A, Wang P, Mueller A, Kawakami A, et al.
Sci Rep
. 2024 Sep;
14(1):21527.
PMID: 39277608
Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte function, development and plays a significant role in melanoma pathogenesis. MITF genomic amplification promotes melanoma development, and it can facilitate...
6.
Linnemann E, Nielsen M, Maul L, Richter C, Dommann I, Zink A, et al.
Int J Dermatol
. 2024 Aug;
63(10):e231-e239.
PMID: 39109412
Background: Biologics are among the most effective therapies for psoriasis. However, many patients are only introduced to them at advanced stages of the disease course. Objectives: Our aim was to...
7.
Constantin D, Nosi V, Kehrer N, Vacchini A, Chancellor A, Contassot E, et al.
Cancer Immunol Res
. 2024 Jul;
12(10):1452-1467.
PMID: 39028853
The MHC class I-related molecule MR1 is ubiquitously expressed, is highly conserved among mammals, and presents bacterial and endogenous antigens in tumor cells. These features indicate that tumor-specific T cells...
8.
Weiss L, Marbet C, Branca L, Muhleisen B, Navarini A
Case Rep Dermatol
. 2024 Jul;
16(1):144-148.
PMID: 39015397
Introduction: After the introduction of dupilumab as systemic treatment for atopic dermatitis, an increasing number of patients have been successfully treated. However, reports of patients developing psoriasis as a secondary...
9.
Schmauch E, Severin Y, Xing X, Mangold A, Conrad C, Johannsen P, et al.
Sci Adv
. 2024 Jul;
10(27):eado2365.
PMID: 38959302
Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease with a poorly understood pathogenesis. Through a molecularly driven precision medicine approach and an extensive mechanistic pathway analysis in PRP...
10.
Forster A, Navarini A, Muehleisen B
Acta Derm Venereol
. 2024 Jun;
104:adv40778.
PMID: 38916181
No abstract available.